Cargando…

Remedicalizing cannabis : science, industry, and drug policy /

"When cannabis tincture was withdrawn as a medical product in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these me...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Taylor, Suzanne (Research fellow) (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Montreal ; Kingston ; London ; Chicago : McGill-Queen's University Press, [2022]
Colección:Intoxicating histories ; 3.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_on1330713484
003 OCoLC
005 20240329122006.0
006 m o d
007 cr un|||||||||
008 220617s2022 quc ob 001 0 eng
040 |a NLC  |b eng  |e rda  |c NLC  |d OCLCF  |d NLC  |d LGG  |d EBLCP  |d N$T  |d YDX  |d UKAHL  |d DEGRU  |d OCLCO  |d OCLCL  |d SFB  |d OCLCL 
015 |a 20220272387  |2 can 
019 |a 1330713564  |a 1330713611 
020 |a 9780228013501  |q ePUB 
020 |a 022801350X  |q ePUB 
020 |a 9780228013495  |q electronic book 
020 |a 0228013496  |q electronic book 
029 1 |a AU@  |b 000075410201 
035 |a (OCoLC)1330713484  |z (OCoLC)1330713564  |z (OCoLC)1330713611 
043 |a e-uk--- 
050 4 |a RM666.C266  |b T39 2022 
055 0 |a RM666.C266  |b T39 2022 
082 0 |a 615.7/827  |2 23 
084 |a cci1icc  |2 lacc 
049 |a UAMI 
100 1 |a Taylor, Suzanne  |c (Research fellow),  |e author. 
245 1 0 |a Remedicalizing cannabis :  |b science, industry, and drug policy /  |c Suzanne Taylor. 
264 1 |a Montreal ;  |a Kingston ;  |a London ;  |a Chicago :  |b McGill-Queen's University Press,  |c [2022] 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Intoxicating histories ;  |v 3 
504 |a Includes bibliographical references and index. 
505 0 |a Understanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964-82 -- Cannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973-82 -- Evidence-Based Policy? The Development of Expert Committees, 1972-82 -- Industrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973-2001 -- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973-2001 -- Establishing Therapeutic Cannabis: The Role of Expert Advice, 1997-2001 -- From Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995-2005 -- Accessing Cannabis-Based Medicinal Products (CBMPS), 2009-21. 
520 |a "When cannabis tincture was withdrawn as a medical product in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalising Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism. Remedicalising Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today's debates about cannabis."--  |c Provided by publisher. 
588 |a Description based on online resource; title from digital title page (viewed on February 15, 2023). 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Cannabis  |x Therapeutic use  |z Great Britain  |x History  |y 20th century. 
650 0 |a Cannabis  |x Government policy  |z Great Britain  |x History  |y 20th century. 
650 0 |a Marijuana industry  |z Great Britain  |x History  |y 20th century. 
650 0 |a Cannabis  |x Therapeutic use  |z Great Britain  |x History  |y 21st century. 
650 0 |a Cannabis  |x Government policy  |z Great Britain  |x History  |y 21st century. 
650 0 |a Marijuana industry  |z Great Britain  |x History  |y 21st century. 
650 6 |a Cannabis  |x Emploi en thérapeutique  |z Grande-Bretagne  |x Histoire  |y 20e siècle. 
650 6 |a Cannabis  |x Politique gouvernementale  |z Grande-Bretagne  |x Histoire  |y 20e siècle. 
650 6 |a Cannabis  |x Emploi en thérapeutique  |z Grande-Bretagne  |x Histoire  |y 21e siècle. 
650 6 |a Cannabis  |x Politique gouvernementale  |z Grande-Bretagne  |x Histoire  |y 21e siècle. 
650 7 |a MEDICAL / History.  |2 bisacsh 
650 7 |a Cannabis  |x Therapeutic use  |2 fast 
650 7 |a Marijuana industry  |2 fast 
651 7 |a Great Britain  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP 
648 7 |a 1900-2099  |2 fast 
653 |a ACMD. 
653 |a CBD. 
653 |a CBMPs. 
653 |a Cannabinoids. 
653 |a Griffith Edwards. 
653 |a INCB. 
653 |a MS. 
653 |a Sativex. 
653 |a Science. 
653 |a Sir William Paton. 
653 |a THC. 
653 |a World Health Organization. 
653 |a bio tech industry. 
653 |a boundary substance. 
653 |a cannabis oil. 
653 |a clinical trials. 
653 |a committees. 
653 |a drug policy. 
653 |a drugs. 
653 |a epilepsy. 
653 |a exchange. 
653 |a expert advice. 
653 |a illicit substances. 
653 |a industry. 
653 |a international agencies. 
653 |a knowledge. 
653 |a marijuana. 
653 |a misuse. 
653 |a oral history. 
653 |a patient access. 
653 |a pharmaceutical. 
653 |a pharmacology. 
653 |a phytopharmacy. 
653 |a plant based medicine. 
653 |a policy. 
653 |a pot. 
653 |a psychopharmacology. 
653 |a tinctures. 
653 |a uncertainty. 
653 |a user activism. 
655 0 |a Electronic books. 
655 7 |a History  |2 fast 
758 |i has work:  |a REMEDICALISING CANNABIS (Text)  |1 https://id.oclc.org/worldcat/entity/E39PD3M6FbWB8TyDd7Tm8KfW9P  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Taylor, Suzanne (Research fellow)  |t Remedicalizing cannabis.  |d Montreal ; Kingston ; London ; Chicago : McGill-Queen’s University Press, 2022  |z 022801140X  |z 9780228011408  |w (OCoLC)1280599221 
830 0 |a Intoxicating histories ;  |v 3. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=30159064  |z Texto completo 
938 |a De Gruyter  |b DEGR  |n 9780228013495 
938 |a Askews and Holts Library Services  |b ASKH  |n AH41240889 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL30159064 
938 |a EBSCOhost  |b EBSC  |n 3546736 
938 |a YBP Library Services  |b YANK  |n 19534801 
938 |a YBP Library Services  |b YANK  |n 304608052 
994 |a 92  |b IZTAP